Model-based optimization of G-CSF treatment during cytotoxic chemotherapy

PURPOSE: Although G-CSF is widely used to prevent or ameliorate leukopenia during cytotoxic chemotherapies, its optimal use is still under debate and depends on many therapy parameters such as dosing and timing of cytotoxic drugs and G-CSF, G-CSF pharmaceuticals used and individual risk factors of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Schirm, Sibylle, Engel, Christoph, Loibl, Sibylle, Loeffler, Markus, Scholz, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794835/
https://www.ncbi.nlm.nih.gov/pubmed/29103159
http://dx.doi.org/10.1007/s00432-017-2540-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794835/
https://www.ncbi.nlm.nih.gov/pubmed/29103159
http://dx.doi.org/10.1007/s00432-017-2540-1

Ejemplares similares